The Adult ADHD Market: A Surge in Female Diagnosis is Reshaping UK Healthcare

The adult ADHD market is experiencing significant growth, driven by a sharp rise in diagnoses among women. While data from the US shows the number of adults with an ADHD diagnosis almost doubled over two decades, the underlying trend is highly relevant for UK health businesses. This shift is creating a large, previously underserved patient population, presenting a clear opportunity for digital health platforms, private clinics and specialised service providers to build new, commercially viable services.

Key takeaways

US market data shows adult ADHD diagnoses grew from roughly 8 million to 15.5 million in two decades, indicating a major trend.

Growth is primarily driven by women identifying their own symptoms during their children's diagnosis process.

Historical diagnostic criteria, based largely on hyperactive boys, meant generations of girls and women were missed.

This creates a new patient demographic of professional women in their 30s, 40s and 50s seeking assessment and treatment.

Providers need specific clinical and commercial teams to capture this expanding market.

The scale of the adult ADHD market opportunity

To understand the potential, we can look to the US market as a leading indicator. In 2023, approximately 15.5 million American adults were living with an ADHD diagnosis. This is a substantial increase from two decades prior, when the figure was around 8 million adults, or 4.4% of the 18 to 44 age group. This is not a small, incremental change, it is a near doubling of a recognised patient population.

This points to a significant unaddressed need. The increase is not due to a sudden rise in incidence, but rather better identification of existing cases. For UK healthcare operators, this signals a latent market that is now becoming active. These are patients who have likely struggled for years and are now actively seeking solutions, representing a clear demand for services.

Who is the new adult ADHD patient?

The primary driver of this growth is the diagnosis of women, often long after they have finished school and established careers. A common pathway to diagnosis, as highlighted by experts, is when mothers go through the assessment process with their own children. They recognise the described symptoms and behaviours in themselves, triggering their own journey to diagnosis.

This phenomenon extends beyond millennial mothers. Dr. David Goodman of Johns Hopkins School of Medicine notes that women in their 50s are having similar realisations, and in turn, identifying probable ADHD in their own mothers, now in their 60s and 70s. The new patient is therefore often a professionally established woman who has developed sophisticated coping mechanisms over decades but is now seeking formal diagnosis and support.

Why is this happening now?

The surge in diagnoses is a result of destigmatisation and evolving clinical understanding. For decades, the archetype of an ADHD patient was a hyperactive young boy. Dr. Lara Litvinov of the Child Mind Institute points out that the criteria in the Diagnostic and Statistical Manual (DSM) are still largely based on data from this group. This created a significant diagnostic bias.

Girls and women often present differently, with less hyperactivity and more internalised symptoms relating to executive function, such as challenges with organisation and attention control. As awareness of these different presentations grows among clinicians and the general public, more women are correctly identified. The process of a child's diagnosis simply acts as the catalyst for this recognition.

What are the service delivery implications?

Serving this new patient cohort requires a different approach from traditional paediatric ADHD services. Providers must design assessment and treatment pathways specifically for adults. This includes acknowledging co-occurring conditions like anxiety and depression, which women may have been treated for previously without addressing the underlying ADHD.

Care models must be flexible to accommodate the lives of working professionals and parents. This creates a strong opportunity for digital health solutions, such as online assessments, virtual therapy, and prescription management. The key is to offer a service that is not only clinically robust but also accessible and discreet, fitting into the complex lives of adult patients.

What this means for hiring

To capitalise on the growing adult ADHD market, health businesses must build specialised teams. This is not simply an extension of existing mental health services. It requires a dedicated strategy supported by the right clinical, commercial and leadership talent.

On the clinical side, demand is rising for Psychiatrists, Clinical Psychologists and ADHD Nurse Specialists with specific expertise in adult assessment and pharmacology. On the commercial side, leaders need to hire Product Managers who can design adult-centric digital pathways and Marketing Directors who can speak authentically to this new patient demographic. Operationally, you need leaders who can build scalable, efficient clinical processes to manage patient flow from assessment to treatment.

At Scale Health, we partner with health businesses to build these exact teams. We understand the specific competencies required to succeed in a new and rapidly growing service line like adult ADHD care. We connect you with the clinical and commercial leaders who can turn market opportunity into a successful reality.

FAQ

What is driving the increase in adult ADHD diagnoses?

The increase is driven by better identification, not a rise in prevalence. Greater public awareness and an updated clinical understanding of how ADHD presents in adults, particularly women, means that cases that were previously missed or misdiagnosed are now being correctly identified.

Why are more women being diagnosed with ADHD now?

More women are being diagnosed because historical diagnostic models were based on hyperactive boys, causing female symptoms to be overlooked. Many women now recognise their own ADHD traits when seeking a diagnosis for their children, prompting them to seek their own assessment as adults.

How large is the adult ADHD market?

While UK-specific figures are emerging, US data provides a strong indicator of the market size. In 2023, 15.5 million US adults had an ADHD diagnosis, up from 8 million two decades earlier. This suggests a significant and growing patient population in Western markets.

What roles are crucial for a business entering the adult ADHD space?

Key roles include clinicians like Psychiatrists and ADHD Nurse Specialists with adult experience. Commercially, Product Managers are needed to build user-friendly services, and Marketing Directors to reach the target demographic. Executive roles like a Head of Operations are vital to ensure the service is scalable and efficient.